Evidence map›Paper›PMID 42602915›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2026

Economic evaluation of wastewater surveillance in Ontario, Canada, using COVID-19 as a case study.

Yeva Sahakyan, David Champredon, Prakathesh Rabeenthira, Alex Rodriguez Barizonte, Manon Fleury, Beate Sander

Abstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yeva SahakyanHealth Systems and Policy Research Collaborative Centre, University Health Network, Toronto, ON.
David ChampredonNational Microbiology Laboratory, Public Health Agency of Canada, Guelph, ON.
Prakathesh RabeenthiraNational Microbiology Laboratory, Public Health Agency of Canada, Guelph, ON.
Alex Rodriguez BarizonteFaculty of Arts & Science, University of Toronto, Toronto, ON.
Manon FleuryNational Microbiology Laboratory, Public Health Agency of Canada, Guelph, ON.
Beate SanderHealth Systems and Policy Research Collaborative Centre, University Health Network, Toronto, ON.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic has stimulated the use of wastewater surveillance (WWS) in Canada. Objective: To inform continued investment, the study assessed the cost-utility of WWS, alongside conventional surveillance, compared to conventional surveillance alone, using COVID-19 in Ontario as an example. Methods: This model-based cost-utility analysis measured WWS effectiveness by increased lead time of 1-10 days for public health response using the Ontario health system perspective. The model integrated SARS-CoV-2 transmission dynamics, SARS-CoV-2 RNA concentration in the sewage system, and disease progression. The analysis considered year-round surveillance with an outbreak occurring once in a decade, assuming WWS benefits accrue only in the outbreak year. At the individual-level, a lifetime time horizon was used and future health outcomes (quality-adjusted life years [QALYs]) and cost were discounted at 1.5%. The model was informed by population-based administrative data and was calibrated to real-world Ontario surveillance data. Results: For Omicron/BA.1-like outbreaks, a WWS program with a $15 million CAD/year budget maintained over 10 years would be cost-effective at a $50,000 CAD/QALY threshold if it detects an outbreak three or more days earlier, and cost-saving if it detects an outbreak 10 or more days earlier than conventional surveillance. For a less severe outbreak with lower transmission rates, e.g., XBB-like, the WWS program would be cost-effective if at least six outbreaks occur in a decade. Conclusion: The study findings suggest that long-term investments in WWS are likely cost-effective for low-frequency but high-impact outbreaks. Maintaining WWS infrastructure will enhance Canada's emergency preparedness for emerging and re-emerging pathogens.

Indexed as

cost-utilityCOVID-19economic evaluationepidemic modeloutbreakSARS-CoV-2wastewater surveillance

Identifiers

PMID42602915
PMCPMC13475503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.